Replies to post #87212 on Biotech Values

[DewDiligence]

Re: Proportion of phase-2 cancer trials randomized

Did you count trials that were randomized to different doses?

I excluded trials designated as “uncontrolled,” which is the proper designation for trials with randomization to different doses of the same regimen. I included randomized trials that are not designated as either “controlled” or “uncontrolled” because the vast majority of these trials do have an active or placebo control arm.

I just reran the numbers and got 24.2% rather than the 25.9% figure I posted previously; I probably screwed up the arithmetic somewhere in the prior calculation.